Signature Wealth Management Partners’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
Other funds holding PFE
Signature Wealth Management Partners's PFE Position: Q2 2025 in Review
Signature Wealth Management Partners sold out of Pfizer (PFE) in Q2 2025, closing a stake of 16,529 shares — an estimated $419K sold.
Signature Wealth Management Partners first reported a position in PFE in Q4 2020 and held it in 18 quarters. The position peaked at $972K in Q4 2021. 2,810 funds tracked by Wall St. Rank hold PFE as of Q2 2025.
- Signature Wealth Management Partners reported no remaining Pfizer position as of Q2 2025 after selling out during the quarter.
- Signature Wealth Management Partners sold 16,529 Pfizer shares in Q2 2025, an estimated $419K.
- Signature Wealth Management Partners first reported a position in Pfizer in Q4 2020 and held it in 18 quarters.
- Signature Wealth Management Partners's Pfizer position peaked at $972K in Q4 2021.
- 2,810 funds tracked by Wall St. Rank held Pfizer as of Q2 2025.
Based on Signature Wealth Management Partners's 13F filing for Q2 2025, filed 22 Jul 2025.